What Is Adempas - Adempas is the first and only treatment for adult patients with pah (who group 1) and inoperable or persistent/recurrent cteph (who group 4). Adempas is the first and only medicine approved by the food and drug administration for treating adults with: Adempas (riociguat) is a soluble guanylate cyclase stimulator used to treat adults with two forms. Adempas (riociguat) is a medication used to treat adults with pulmonary arterial hypertension (pah) and chronic. Adempas is the first member of a drug class called soluble guanylate cyclase (sgc) stimulators.
Adempas (riociguat) is a medication used to treat adults with pulmonary arterial hypertension (pah) and chronic. Adempas (riociguat) is a soluble guanylate cyclase stimulator used to treat adults with two forms. Adempas is the first and only medicine approved by the food and drug administration for treating adults with: Adempas is the first member of a drug class called soluble guanylate cyclase (sgc) stimulators. Adempas is the first and only treatment for adult patients with pah (who group 1) and inoperable or persistent/recurrent cteph (who group 4).